Type 2 Diabetes

BOSTON — In this Healio video exclusive, Viral Shah, MD, discusses insulin delivery systems for patients with type 2 diabetes.

HOUSTON — A mobile health program that includes home visits from a health coach may be able to reduce racial and ethnic disparities and improve HbA1c for Black and Hispanic adults with type 2 diabetes, according to two speakers.

It is not uncommon for endocrinologists to treat adults with both diabetes and thyroid disease.

DALLAS —Behavioral weight management combined with diabetes education is linked to greater weight loss and a higher likelihood for diabetes remission for adults with new-onset type 2 diabetes, according to two speakers at ObesityWeek.

Higher initial glucose levels and increasing BMI over time could serve as predictors of progression from prediabetes to type 2 diabetes for children and adolescents, according to findings published in the Journal of the Endocrine Society.

Novo Nordisk has ended a clinical trial evaluating the impact of semaglutide on kidney function after the results from an interim analysis met certain pre-specified criteria, according to a company press release. To protect the integrity of the trial, Novo Nordisk will remain blinded to the results until the trial is completed, likely during the first half of 2024, according to the release. 

Tirzepatide led to greater HbA1c and body weight reductions compared with placebo or semaglutide in people with type 2 diabetes, according to a meta-analysis of randomized trials.

Testosterone therapy may reduce HbA1c for men with type 2 diabetes and hypogonadism, according to a presenter at the European Association for the Study of Diabetes annual meeting.

Spending more time in natural light may help improve metabolism for adults with type 2 diabetes, according to data from a small study presented at the European Association for the Study of Diabetes annual meeting.

The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as well as increased risk for hypoglycemia if used in combination with insulin or insulin secretagogue.